Crispr Therapeutics Ag (CRSP) returns
Crispr Therapeutics Ag returns over 10 years
$1,000 invested in Crispr Therapeutics Ag ten years ago was worth $3,072 at the close on October 30, 2026, with dividends reinvested: an average return of 11.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -7.0% | — | $929.50 | -0.9% |
| 3 months | +6.2% | — | $1,062 | +2.1% |
| Year to date | -1.9% | — | $980.55 | +11.7% |
| 1 year | -15.8% | — | $841.57 | +12.4% |
| 3 years | +32.1% | +9.7% | $1,321 | +88.5% |
| 5 years | -43.7% | -10.9% | $563.01 | +76.0% |
| 10 years | +207.2% | +11.9% | $3,072 | +316.6% |
Crispr Therapeutics Ag return by calendar year
| Year | CRSP | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -1.9% | +11.7% | -13.6% |
| 2025 | +33.2% | +17.7% | +15.5% |
| 2024 | -37.1% | +24.9% | -62.0% |
| 2023 | +54.0% | +26.2% | +27.8% |
| 2022 | -46.4% | -18.2% | -28.2% |
| 2021 | -50.5% | +28.7% | -79.3% |
| 2020 | +151.4% | +18.4% | +133.0% |
| 2019 | +113.2% | +31.2% | +82.0% |
| 2018 | +21.7% | -4.6% | +26.2% |
| 2017 | +15.9% | +21.7% | -5.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CRSP financials
No forecast, no recommendation. This page describes Crispr Therapeutics Ag from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.